A new urine test performed better than PSA-based testing and MRI for monitoring low-risk prostate cancers on active ...
A new GLP-1 weight loss drug called survodutide has shown promising results in a phase 3 clinical trial. The drug, which ...
Mark Gurarie is a writer covering health topics, technology, music, books, and culture. He also teaches health science and research writing at George Washington University's School of Medical and ...
Potency assay development uses DoE and QbD to improve accuracy, consistency, and regulatory readiness in biologics testing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results